Author: President's Council on Bioethics (U.S.)
Publisher:
ISBN:
Category : Bioethics
Languages : en
Pages : 440

Get Book

Book Description

Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309170427
Category : Science
Languages : en
Pages : 112

Get Book

Book Description
Recent scientific breakthroughs, celebrity patient advocates, and conflicting religious beliefs have come together to bring the state of stem cell researchâ€"specifically embryonic stem cell researchâ€"into the political crosshairs. President Bush's watershed policy statement allows federal funding for embryonic stem cell research but only on a limited number of stem cell lines. Millions of Americans could be affected by the continuing political debate among policymakers and the public. Stem Cells and the Future of Regenerative Medicine provides a deeper exploration of the biological, ethical, and funding questions prompted by the therapeutic potential of undifferentiated human cells. In terms accessible to lay readers, the book summarizes what we know about adult and embryonic stem cells and discusses how to go about the transition from mouse studies to research that has therapeutic implications for people. Perhaps most important, Stem Cells and the Future of Regenerative Medicine also provides an overview of the moral and ethical problems that arise from the use of embryonic stem cells. This timely book compares the impact of public and private research funding and discusses approaches to appropriate research oversight. Based on the insights of leading scientists, ethicists, and other authorities, the book offers authoritative recommendations regarding the use of existing stem cell lines versus new lines in research, the important role of the federal government in this field of research, and other fundamental issues.

Author: The President's Council on Bioethics
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

Get Book

Book Description

Author: National Bioethics Advisory Commission
Publisher: Government Printing Office
ISBN: 9780160879005
Category :
Languages : en
Pages : 438

Get Book

Book Description
NOTE: NO FURTHER DISCOUNT FOR THIS PRINT PRODUCT. Significantly reduced price. Overstock List Price. January 2004. Summarizes some of the more interesting and significant recent developments, both in the basic science and medical applications of stem cell research and in the related ethical, legal, and policy discussions. Seeks to shed light on where we are now: ethically, legally, scientifically, and medically, in order that the President, the Congress, and the nation may be better informed as they consider where we should go in the future. Related products: Health & Benefits resources collection can be found here: https: //bookstore.gpo.gov/catalog/health-benefits

Author: President's Council on Bioethics (U.S.)
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 450

Get Book

Book Description
This report summarizes some of the more interesting and significant recent developments, both in the basic science and medical applications of stem cell research and in the related ethical, legal, and policy discussions. It does not attempt to be a definitive or comprehensive study of the whole topic. It contains no proposed guidelines and regulations, nor indeed any specific recommendations for policy change. Rather, it seeks to shed light on where we are now: ethically, legally, scientifically, and medically, in order that the President, the Congress, and the nation may be better informed as they consider where we should go in the future.

Author: President's Council on Bioethics
Publisher:
ISBN:
Category :
Languages : en
Pages : 414

Get Book

Book Description

Author:
Publisher:
ISBN:
Category : Bioethics
Languages : en
Pages :

Get Book

Book Description

Author: Babak Arjmand
Publisher: Springer Nature
ISBN: 3030277275
Category : Science
Languages : en
Pages : 199

Get Book

Book Description
This book provides thorough coverage of high-throughput OMICs technologies for the monitoring of stem cells and regenerative medicine. Specific topics covered include the genomics, proteomics, and metabolomics aspects of regenerative medicine, metabolic profiling of mesenchymal stem cells, genome profiling of mesenchymal stem cells, OMICs monitoring of stem cell-derived exosomes, stem cell proteomics, lipidomics, OMICs profiling of cancer (stem) cells, and finally ethical considerations of OMICs-based investigations. Chapters are authored by world-renowned scientists who have valuable expertise in the field of OMICs and regenerative medicine. Genomics, Proteomics, and Metabolomics: Stem Cells Monitoring in Regenerative Medicine, part of Springer’s Stem Cell Biology and Regenerative Medicine series, is essential reading for researchers, clinicians, biologists, biochemists, and pharmaceutical experts conducting research in the fields of stem cell biology, molecular aspects of stem cell research, tissue engineering, regenerative medicine, cellular therapy, OMICs, bioinformatics, and ethics.

Author: Audrey R. Chapman
Publisher:
ISBN:
Category : Stem cells
Languages : en
Pages : 54

Get Book

Book Description

Author: Adam C. Berger
Publisher: National Academy Press
ISBN: 9780309303002
Category : Medical
Languages : en
Pages : 108

Get Book

Book Description
Stem cells offer tremendous promise for advancing health and medicine. Whether being used to replace damaged cells and organs or else by supporting the body's intrinsic repair mechanisms, stem cells hold the potential to treat such debilitating conditions as Parkinson's disease, diabetes, and spinal cord injury. Clinical trials of stem cell treatments are under way in countries around the world, but the evidence base to support the medical use of stem cells remains limited. Despite this paucity of clinical evidence, consumer demand for treatments using stem cells has risen, driven in part by a lack of available treatment options for debilitating diseases as well as direct-to-consumer advertising and public portrayals of stem cell-based treatments. Clinics that offer stem cell therapies for a wide range of diseases and conditions have been established throughout the world, both in newly industrialized countries such as China, India, and Mexico and in developed countries such as the United States and various European nations. Though these therapies are often promoted as being established and effective, they generally have not received stringent regulatory oversight and have not been tested with rigorous trials designed to determine their safety and likely benefits. In the absence of substantiated claims, the potential for harm to patients - as well as to the field of stem cell research in general - may outweigh the potential benefits. To explore these issues, the Institute of Medicine, the National Academy of Sciences, and the International Society for Stem Cell Research held a workshop in November 2013. "Stem Cell Therapies" summarizes the workshop. Researchers, clinicians, patients, policy makers, and others from North America, Europe, and Asia met to examine the global pattern of treatments and products being offered, the range of patient experiences, and options to maximize the well-being of patients, either by protecting them from treatments that are dangerous or ineffective or by steering them toward treatments that are effective. This report discusses the current environment in which patients are receiving unregulated stem cell offerings, focusing on the treatments being offered and their risks and benefits. The report considers the evidence base for clinical application of stem cell technologies and ways to assure the quality of stem cell offerings.